| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_eaf7ef3f1bf6e69de54fafc32149b970 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-113 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-11 |
| filingDate |
2019-10-09^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_797143fae28789bae32ad75ad4117491
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0f2d11e00013e2fc17e77da98c5dcbaf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e1a36d5315f45224580ee7cfd0ba65e6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7b7baa39c25bf468bdc959b3f060e0cd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_04a46168ad8cb7ea5458f136d9a83c27
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_30a77d355d75367e69720b0c86b3889a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6e869db1039db65cac49588c15506e63
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c397000e61e0b0e607ae73aa9615c87f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1d60b1b8821c9dfba47429ed9832a180
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_35c9b0b0fbeaef296f1a3d4d58f48afa |
| publicationDate |
2020-04-23^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2020081329-A1 |
| titleOfInvention |
Methods and compositions for modulating pcsk9 and angptl3 expression |
| abstract |
Provided herein are methods for modulating PCSK9 or ANGPTL3 expression by administering compounds that affect PCSK9 or ANGPTL3 transcription factors or signaling pathways. Also provided are methods for treating subjects with diseases associated with high LDL-cholesterol by administering compounds that modulate PCSK9 or ANGPTL3 expression. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2021369690-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-115260519-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-115260519-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-115282148-A |
| priorityDate |
2018-10-18^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |